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Background: Cardiovascular Disease (CVD) is a major cause of mortality worldwide. Control and reduction of
cardiovascular risk factors such as elevated blood pressure, high cholesterol levels, excess of body weight, smoking
and lack of exercise can contribute to a reduction of CVD mortality.
Methods: A standardized questionnaire was administered to all medical officers willing to participate in the study,
who were working in the Cardiology Units all over Sri Lanka to assess the source of continuous medical education,
attitudes on secondary prevention, barriers to secondary prevention and knowledge assessment of secondary
prevention of cardiovascular diseases. Chi square was used to compare groups and p < 0.05 was considered
significant.
Results: 132 participants with equal numbers of males and female doctors participated. While 56 doctors have had
no training in cardiology, 75 doctors have had some training in a cardiology unit. The barriers for secondary
prevention were, poor knowledge/understanding of patients 3.82 (1.06), too many drugs 3.74 (0.98), presence of
co-morbid conditions 3.68(0.97), cost of medications 3.69 (0.97) and poor adherence to prevention strategies by
patients 3.44 (1.15). Routine clinic visits 85 (65%) and public awareness day seminars 30 (22.2%) were the most
effective methods of secondary prevention. Guidelines were the most popular method of continuous medical
education. Those who have had some training in cardiology did not differ in their knowledge from those who have
never had training in cardiology. Knowledge about prevention with regard to diet was inadequate and exercise
and lipids were adequate but not good. Rates of knowledge on smoking cessation were much higher than for
other CVD risk factors.
Conclusion: There needs to be more adherences to clinical guidelines and attention paid to CVD prevention, in
particular, the importance of dietary modifications, adequate exercise, and lipid control.
Keywords: Cardiovascular disease prevention, Coronary heart disease, Secondary prevention, Sri Lanka, Continuous
medical educationBackground
Cardiovascular Disease (CVD) is a major cause of mortal-
ity worldwide. Studies have proven that control and reduc-
tion of cardiovascular risk factors such as elevated blood
pressure, high cholesterol levels, excess of body weight,
smoking and lack of exercise can contribute to a reduction
of CVD mortality of around 40-60% [1].* Correspondence: thushara.matthias@gmail.com
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unless otherwise stated.To optimally manage the risk factors for CVD, the
risk factors must be identified. This will enable risk
stratification of patients with CVD. There are different
risk estimation scores: SCORE [2], Framingham [3] and
ASSIGN–SCORE [4]. Risk factor estimations are import-
ant as atherosclerosis is a multifactorial disease. These risk
estimation scores are built on the ideal target levels for
each risk factor. The targets are values at which each risk
factor control is started. A group of modestly deranged
risk factors can result in a higher total risk than a single
deranged risk factor as multiple risk factors givel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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CVD risk-estimation system should be methodologically
robust, easy to use and should have a beneficial out-
come [5]. Though risk factor estimation systems should
theoretically improve outcomes, not many studies have
proven the above [5]. Therefore as of now, until the
actual benefits of risk-factor estimation systems can be
proven, everyday clinical practice should involve the
assessment of risk factors and control of them. In order
to control risk factors one needs to be aware of the
target level for each factor. Though at present there are
no studies done to prove that knowing the targets for
each risk factor is beneficial, knowing the targets for
each risk factor would enable physicians to participate
to secondary prevention in an active way. The concept
of controlling each risk factor at a particular threshold
is a controversial concept as CVD risk is a continuum
[6]. Yet until further trials are available comparing the
effects of controlling individual risk factors versus total
risk factor control of a patient, it is wise to control a risk
factor once identified.
The targets for risk factors control change from time
to time. They are the result of extensive of clinical re-
search. In an attempt to standardize and improve care,
international health agencies have published guidelines
for secondary prevention of cardiovascular risk factors.
The European Society of Cardiology and American
Heart Association [7], National High Blood Pressure
Education Program committee (JNC 7) [8], and National
Cholesterol Education Panel (ATP III) [9] are some of
them.
Studies assessing the knowledge and efforts of doctors
in secondary prevention have found that doctors do not
stress enough on the role of secondary prevention to
their patients [10]. Lack of awareness about prevention
guidelines [11] and lack of motivation [12] could be pos-
sible reasons. The lack of adherence to guidelines leads to
erroneous or suboptimal management of risk factors.
The objectives of this study were to assess the know-
ledge on secondary prevention among medical officers, to
find out the methods of Continuous medical education
(CME) among medical officers and to find out their
perceived role in risk factor prevention.
CME is one powerful method of bridging the gap be-
tween evidence based medicine and clinical practice.
Ongoing CME is an important area for the maintenance
of good quality clinical care [13]. In most countries in
South Asia, though there are various continuing medical
education programs, there is no revalidation process and
no established system of awarding credits for educational
activities [14]. Sri Lanka is a developing country and there
is no established compulsory continuous medical edu-
cation program or revalidation process in Sri Lanka at
present. There is a National Continuous ProfessionalDevelopment Program, which is voluntary [14,15]. There
is a dearth of data from Sri Lanka on the impact of con-
tinuing medical education programs in general. No studies
have been done on knowledge assessment on secondary
prevention of cardiovascular disease in Sri Lanka. This
study hopes to fulfill the above objectives with the aim of
better secondary prevention of cardiovascular risk factors
in the country.
Methods
Ethical clearance was obtained from the Ethical Review
Committee of the National Hospital of Sri Lanka (NHSL).
A standardized questionnaire (Additional file 1: Question-
naire) was administered to all medical officers who were
working in the Cardiology Units all over Sri Lanka and
the medical officers working in the medical wards of the
National Hospital of Sri Lanka. Informed consent was
obtained. All participants who were willing to take part
were administered the questionnaire.
Development of questionnaire
The questionnaire consisted of three parts.
Part 1 - Demographic details of the participants
Part 2 - Source of CME
Part 3 - Attitudes on secondary prevention. Barriers to
secondary prevention were given and the participants
were asked to rate on a 1–5 likert scale. 1 been not a sig-
nificant barrier and 5 been very significant barrier.
Part4 - Knowledge assessment of secondary prevention.
This part was further subdivided in to prevention of smok-
ing, blood pressure control, lipids, dietary management,
alcohol use, physical activity, weight, management of
diabetes, drugs therapy. This included questions regard-
ing the targets for optimal control for each of the above
and important questions on prevention. They were open
ended questions.
The questionnaire was developed by the authors who
included a Senior Consultant cardiologist. The targets
expected were based on the present guidelines applicable
at the time of study namely: AHA/ACCF Secondary
Prevention and Risk Reduction Therapy for Patients
With Coronary and Other Atherosclerotic Vascular
Disease: 2011 Update [7], National High Blood Pressure
Education Program committee (JNC 7) [8], and National
Cholesterol Education Panel (ATP III) [9] and ACCORD
trial.
Statistical analysis was done using SPSS V.17.0 (SPSS
inc. Chicago, IL). Chi square and t test was used for data
analysis. The level of significance was <0.05.
Results
Participant characteristics
A total of 132 participants with equal numbers of male
and female doctors responded to the questionnaire. The
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30–40 years. The mean age was 33. The number of doc-
tors in a post graduate training program (Registrars and
Senior Registrars) was 41. While 56 doctors have had
no training in cardiology, 75 doctors have had some
training in a cardiology unit. The demographic details
are given in Table 1.
Awareness about guidelines and barriers to adherence
Among the leading reasons the participants sighted as











Colombo North Teaching Hospital 1(0.7)
Colombo South Teaching Hospital 9(6.8)
Matara 5(3.7)
National Hospital of Sri Lanka (NHSL) 86(65.1)
Peradeniya 1(0.7)










Training/working in cardiology unit
No training 56(42.4)
<1 year 47(35.6)
1- 4 years 20(15.15)
>4 years 9(6.8)
Rank
Inter medical officer 26(19.6)
Medical officer 66(0.5)
Registrar 30(22.72)
Senior registrar 11(8.3)understanding of patients 3.82 (1.06), too many drugs
3.74 (0.98), presence of co-morbid conditions 3.68(0.97),
cost of medications 3.69 (0.97) and poor adherence to
prevention strategies by patients 3.44 (1.15). The barriers
to guideline adherence given by participants are listed in
Table 2.
Routine clinic visits 85 (65%) and public awareness day
seminars 30 (22.2%) were the most effective methods of
secondary prevention. Guidelines were the most popular
method of continuous medical education among the
participants (Table 2).Lifestyle, smoking recommendations and lipids, diabetes
and blood pressure management
The knowledge and adherence to guideline recommen-
dation on lifestyle modification, smoking prevention,
lipid, blood pressure and diabetes management are
given in Table 3.
A modest number of participants 40(29.6%) advised
patients to engage in physical activity more than 5 times
a week as recommended by the guidelines. The minimum
duration of 30 minutes was also a well known factor
among this group of doctors (58.5%).Table 2 Data on secondary prevention
Number(Percentage)
Method of secondary prevention
Routine clinic visits 85(65%)
Public awareness day seminars 30(22.2%)
Visits to General practioners 15(11.1%)
Consultations with consultant cardiologists 3(2.2%)
Barriers to secondary prevention Mean(Standard deviation)
Adverse effects of drugs 2.51(1.10)
Patient adherence 3.44(1.15)
Presence of co-morbid conditions 3.68(0.97)
Cost of medications 3.69(0.97)
Too many drugs 3.74(0.98)
Poor knowledge/understanding of patients 3.82(1.06)
Not enough time 2.76(1.23)
Lack of knowledge of doctor 2.58(1.15)
Recommendation on prevention are unclear 2.62(1.00)
Receive little or no training in prevention 2.96(1.10)
Not interested in prevention 3.07(1.21)
Value acute care more than preventive care 3.25(1.26)




Consultations with specialists 49(36.3)
Table 3 Knowledge on secondary prevention and knowledge among those who has training versus those who did not
have training in cardiology








Ask about tobacco use status at the initial visit 128(94.8) 53 73 0.657
Advise every tobacco user to quit 124(91.9) 51 71 0.069
Assist by counseling and developing a plan for quitting or
pharmacotherapy (including nicotine replacement and bupropion)
53(39.3) 16 36 0.068
Arrange follow up, referral to special programs 52(38.5) 27 25 0.068
Questions regarding passive exposure to smoke 70(51.9) 30 39 0.856
Blood pressure targets
What is the systolic blood pressure (SBP) target for patients
without Diabetes mellitus (DM) or Chronic kidney disease (CKD)
60(44.47) 23 36 0.593
What is the DBP target for patients without DM or CKD 53(39.3) 22 30 0.716
What is the target for patients with DM or CKD 60(44.4) 21 39 0.365
What is the target for patients with DM or CKD 18(13.3) 23 41 0.366
Lipid Lowering targets
What is the goal of low density lipoproteins (LDL) for secondary prevention? 55(40.7) 23 31 0.090
What is the goal of non high density cholesterol (HDL) cholesterol if triglyceride
(TG) > 200 mg/dl?
14(10.4) 3 11 0.090
What is the goal of non high density cholesterol (HDL) if triglyceride
(TG) > 200 mg/dl?
18(13.3) 7 11 0.254
What is the dose of Atorvastatin you would prescribe? 0 10 11 0.354
40 mg 0 0 0 0
80 mg
What is the level of TG at which you would initiate therapy with Niacin/Fibrate
before statin?
21(15.6) 9 12 0.270
Fat intake in diet
How much of fat can an average adult take for a day in grams? 4(3) 0 0 0.562
What is the % of polyunsaturated fatty acids (PUFA) out of total fat intake? 14(10.4) 4 9 0.393
What is the % of monounsaturated fatty acids (MUFA) 8(5.9) 0 0 0.007
What is the % of Saturated fatty acids? 12(8.9) 2 6 0.465
What is the amount of recommended daily salt intake in grams/teaspoons? 37(27.4) 14 22 0.561
Alcohol intake
What is the amount of alcohol which is safe to consume for men? 49(36.3) 4 15 0.000
What is the amount of alcohol which is safe to consume for women? 51(37.8) 2 16 0.000
Physical exercise
What is frequency of exercise per week? 40(29.6) 27 27 0.214
What is the duration per session? 79(58.5) 34 56 0.089
Waist circumference and weight
What is the optimal waist circumference for men? 33(24.5) 18 15 0.578
What is the optimal waist circumference for women? 28(20.7) 15 15 0.157
What is the goal of HBA1c?
6.9 1(0.7) 1 0 0.520
7 62(45.9) 32 30 0.217
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Table 3 Knowledge on secondary prevention and knowledge among those who has training versus those who did not
have training in cardiology (Continued)
Drug therapy
Is ACEI indicated in all patients with EF < 40% with no contraindication? 89(65.9) 33 56 0.652
Would you prescribe beta blockers to all patients after ACS if there are no
contraindications?
113(83.7) 44 68 0.483
Aspirin duration after an episode of acute coronary syndrome 83(61.5%) 40 57 0.654
Aspirin dose after an episode of acute coronary syndrome 99(73.4%) 28 53 0.088
Clopidogrel dose after an episode of acute coronary syndrome 100(74%) 38 61 0.073
Clopidogrel duration after an episode of acute coronary syndrome 29(21.5%) 5 5 0.074
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pressure targets set up by the AHA for general population,
but the targets for patients with Diabetes and Kidney
disease were not identified as frequently as the above.
About 40.7% participants identified the LDL target of
100 mg/dl as ideal but only 18% were able to give the cor-
rect dose of Atorvastatin for treatment. There was moder-
ate understanding about triglyceride level management as
only 21% were able to give the target at which treatment
should be started before a statin.
Majority of doctors did not specify the exact targets
for fat intake. The overall response rates for fat intake
been all less than 10.4%. The recommended alcohol intake
for men (36.3%) and women (37.8%) both were identified
by a significant number of participants.
The waist circumference cut off specific for Asians were
identified by a 24.5% and 20.7% of doctors. The goal of
HBAIC of 7 was correctly identified by 62 (5.9%) of the
participants.
The use of Aspirin and Clopidogrel was well known
among the participants and there was a response over 80%
about the correct dose and duration of Aspirin. The know-
ledge about the duration of Clopidogrel was only 29%.
When comparing the two groups of participants, those
who have had some training in cardiology versus those
who have never had training in cardiology, there was no
difference in the level of knowledge.
Discussion
There are issues with regard to the generizability of studies
done on knowledge assessment. This preliminary study on
the knowledge on secondary prevention of cardiovascular
diseases among medical officers is the first of its kind done
in Sri Lanka and it reveals several important findings. The
findings are relevant in three areas: the level of knowledge
on secondary prevention among medical officers, strat-
egies and obstacles to secondary prevention and methods
of CME used by doctors.
Knowledge on secondary prevention
Counseling may be an effective tool in reducing behavioral
risk factors for CVD. Yet, doctors do not counsel theirpatients aggressively about lifestyle changes to prevent
CVD. In our study the knowledge about prevention with
regard to diet was inadequate and exercise and lipids were
adequate but not good. Rates of knowledge on smoking
cessation was much higher than for other CVD risk
factors, a finding which has been reported by others
[16]. Only a handful of physicians knew about the
exact dietary recommendations for fat and salt and the
frequency of exercise needs. Over the past few decades
there has been a consistent need for the change of diet-
ary habits to prevent cardiovascular deaths. This has
been addressed in many leading papers on the subject
[17]. Yet the knowledge on the dietary recommenda-
tion still remains poor. This calls for a more vigorous
shift in the attitudes and knowledge of doctors on diet-
ary recommendations. Over 90% asked about tobacco
use at the initial visit and over 50% advised on quitting
smoking. The knowledge on secondary prevention of
smoking was excellent.
Our study also indicated there is more education needed
in blood sugar control targets and blood pressure targets
as evidence by a similar study done in USA [18] Blood
pressure control plays a vital role in the prevention of
CVD. In a recent meta-analysis it was found that blood
pressure reduction of 10 mmHg systolic or 5 mmHg
diastolic reduced the rate of coronary heart disease by
22% [19].
Lower the serum LDL-cholesterol level, the better it is
for cardiovascular disease prevention [20]. Yet not many
doctors identified the importance of proper lipid control
and they were not certain about the targets for lipid con-
trol. The kowledge on lipids was inadequate. This was also
revealed by a study done by Freedman et al. In another
study done in Germany the knowledge on lipid control
was similar to our study [16]. There need to be more edu-
cational activities to ensure doctors practice the lipid con-
trol guidelines more accurately.
The benefit of Clopidogrel for secondary prevention
after an episode of acute coronary syndrome had been
shown by many multicentre clinical trials [21]. Yet the
duration of Clopidogrel use is not very clear in literature
and our respondents were doubtful about the appropriate
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made on the introduction of evidence based medicine to
our setting.
The limited adherence shown to clinical guidelines has
been termed clinical inertia. The reasons that could con-
tribute to inertia are doctors overestimating the quality of
the care they actually provide, lack of training, and use of
“soft excuses” to avoid intervention [22]. In our study we
found there was very little clinical inertia when it came to
prescribing beta blockers and ACE inhibitors, two drug
classes which have morbidity and mortality benefit cardio-
vascular disease prevention. In our study most doctors
(>60%) knew the exact indications for beta blockers and
ACE Inhibitors. It is therefore safe to assume they would
be prescribing it to all patients who need both the classes
of drugs.
This study also showed that awareness and incorpor-
ation of CVD prevention did not differ by the training
doctors received. The doctors who have not received car-
diology training were equally knowledgeable as those who
hadn’t received training. Our study explored whether
physician training level was predictive of adherence to
guidelines. The data form Friedman et al. found that
attending physicians and resident physicians did not
differ in prevention counseling. The reasons given were
that attending physicians did not believe in physician
counseling and also were not very knowledgeable in the
present guidelines [23].
Strategies of secondary prevention
There is gap in what is mentioned in clinical guidelines
and what is practiced in the sphere of secondary preven-
tion in CVD. The real issue in cardiovascular medicine is
implementation of these recommendations into clinical
practice [24]. In an attempt to bridge this gap, heath care
providers and patients both need to take action [25].
Though there are several available methods of secondary
prevention, not many are evidenced based. Until such
time evidence becomes available it is wise to take in to ac-
count what the physicians think are the most appropriate
methods and utilize them to educate patients. When asked
from doctors in our study clinic visits were the best ap-
proach to educate patients. This is in contrast to the
popular belief that a one to one consultation with a con-
sultant or specialist is more useful. Regular clinic visits
allowed a proper follow up plan to be implemented.
The value of clinics in secondary prevention has been
reported elsewhere in the world. A day clinic where
patients are educated regarding secondary prevention
has found to be very effective [26]. Yet the difference in
these clinics done elsewhere in the world, they have less
volume of patients, the clinic is primarily focused on
secondary prevention and special lectures on athero-
genesis and nutrition and an individualized care plan ismade at the end of the day. To uplift the status of the
secondary prevention in our country will be a difficult
task only through clinics because our clinics cater to a
massive number of patients, limited time available to
devote for each patient and the clinics are mainly run
by doctors with no involvement of nursing staff who
could be useful in advising patients.
Therapeutic patient education [27] might be one method
a country like Sri Lanka should try implementing. Sri
Lanka has Cardiac Rehabilitation Programs in several
leading hospitals. These have proven to be effective
which indicates patients should be and can be used
effectively for secondary prevention of CVD [28].
Barriers to secondary prevention
Over time, studies done all over the world have highlighted
several obstacles for optimal cardiovascular disease pre-
vention. The main obstacles identified were lack of time
[23], lack of understanding of patients about the disease
and adherence to life style modifications [18], the high
cost of medication and inadequate time for counseling
[29]. The main barriers to secondary preventions as seen
by doctors in our study were: poor knowledge of the pa-
tients, too many drugs and high cost of medications and
the fact that patient values acute care more than prevent-
ive care. These barriers were common to Europe as well
as Asia as evident by the REACT study [23,30]. Sri Lanka
is still a developing country and the majority of patients
who utilize the free health care system are not advanced
enough to look up and read about their illnesses and learn
about them. Poor knowledge of patients was considered a
major problem by our respondents. Lack of knowledge is
a significant barrier in developing nations [30]. Patients
participation been crucial to CVD prevention has been
highlighted by studies before [16,18]. In order to overcome
the barriers in our setting several important measures
could be implemented. We can learn from studies which
have proven the efficacy of these methods [30]. To educate
patients, patent information leaflets can be utilized. Self
care diary maintenance can be promoted. Sri Lanka at
present does not have an official referral and counter re-
ferral system and any patient can seek treatment from any
government or private sector health care facility as and
when they wish. This leads to overcrowding of tertiary
care centers which leads to less time spent on patients. An
organized referral and counter referral system if imple-
mented can bring a drastic improvement in the patient
care system as duplication of work will be avoided and pa-
tients will be given more care which is continuous.
Continuous medical education
Practice guidelines were found to be the most common
method of CME in our study. This is in contrast to some
studies done previously [31]. CME resources are one of
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study population. CME was preferred over clinical practice
guidelines in studies done elsewhere [20]. CME programs
are always found to be useful to educate and keep the
practicing medical officers up-to-date on the new develop-
ments in the field. This highlights the need for improve-
ment in the CME programs in the country [32].Limitations and future directions
Our study was small. The questionnaire was not subjected
to validity tests. The results may not be generalizable to all
physicians in the country. Our study also lacked the power
to examine whether barriers to treatment varied by age,
gender, or race/ethnicity of the physician. However, since
our findings indicate a low level of adherence to guide-
lines, this adds weight to the concern that doctors may be
under counseling for CVD prevention. Further larger
studies should be carried out to follow up patient’s long
term and determine the effect of risk factor control on
morbidity and mortality of CVD.Conclusion
Overall, this study highlights the need for more CME
among doctors to improve secondary prevention of
cardiovascular diseases. It also highlights the need for a
more robust setup at state hospitals to incorporate
nursing staff and other health professionals in running
clinics. This might help provide a more qualitative ser-
vice to patients. Passive dissemination of information
is not enough for cardiovascular prevention. Logistically
and financially there needs to be a system in place so phy-
sicians can exercise proper secondary prevention activities
and as highlighted before by many studies more aggressive
CME are needed and the mere existence of guidelines will
never be enough.
In summary, our study adds to the growing body of
literature there needs to be more adherences to clinical
guidelines and attention paid to CVD prevention, and,
in particular, the importance of diet, exercise, and lipid
control. Most importantly, our study did not find any
differences in counseling practices between those who
have training in cardiology versus those who did not
have training finding that highlights the need to create
more educational activities to educate both groups.Additional file
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